II. Indications
- HIV Infection (combination therapy)
- Chronic Hepatitis B Infection (Coinfected with HIV)
III. Mechanism
- Nucleoside Reverse Transcriptase Inhibitor
- Emtricitabine is 5-Fluorothiocytidine (FTC), a substituted analog of cytosine (similar to Lamivudine)
IV. Precautions
- Risk of severe HBV exacerbation on discontinuation
- Monitor for at least 2 months after discontinuation
V. Medications
VI. Dosing: HIV Infection
- See HIV Preexposure Prophylaxis
- Used in combination with other HIV agents (e.g. Tenofovir)
- Adult (or child weight >33 kg)
- Emtricitabine 200 mg orally daily
- Child (weight <33 kg)
- Age 0 to 3 months: 3 mg/kg orally daily
- Age >3 months: 6 mg/kg (up to 240 mg) orally daily
- Weight >33 kg: See Adult dosing
VII. Dosing: Chronic Hepatitis B Coinfection with HIV (not FDA approved)
- Emtricitabine 200 mg orally daily AND
-
Tenofovir
- CrCl >=30 ml/min: Tenofovir Alafenamide (Descovy) 25 mg orally daily
- CrCl >=60 ml/min: Tenofovir Disopoxil (Truvada) 300 mg orally daily
VIII. Dosing: Renal (Adult)
-
CrCl 30 to 49 ml/min
- Take 200 mg capsule orally every 48 hours (or 120 mg oral solution daily)
-
CrCl 15 to 29 ml/min
- Take 200 mg capsule orally every 72 hours (or 80 mg oral solution daily)
-
CrCl <15 ml/min or Hemodialysis
- Take 200 mg capsule orally every 96 hours (or 60 mg oral solution daily)
IX. Adverse Effects: Emtricitabine alone
- See nRTI for adverse effects attributed to the class
- Minimal specific adverse effects and well tolerated
- Hyperpigmentation of palms and soles
- Hepatitis B infection flares on withdrawal of medication
X. Adverse Effects: Emtricitabine with Tenofovir (Truvada, Descovy)
- See Tenofovir
- Start-up syndrome (Nausea, Abdominal Pain, Flatulence, Headache) which typically resolves after the first month
-
Hepatitis B
Virus flare
- Associated with abrupt cessation of Antiretroviral therapy
- Acute Renal Failure
XI. Safety
XII. Resources
- Emtricitabine (DailyMed)
- Truvada - Emtricitabine AND Tenofovir Disopoxil (DailyMed)
- Descovy - Emtricitabine with Tenofovir Alafenamide (DailyMed)
Images: Related links to external sites (from Bing)
Related Studies
emtricitabine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB | Generic | $0.56 each |
truvada (on 7/20/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
TRUVADA 200 MG-300 MG TABLET | Generic | $0.56 each |
descovy (on 1/1/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
DESCOVY 200-25 MG TABLET | $66.13 each |